Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vandetanib and Anastrozole in HR+ Breast Cancer
NCT00481845Phase 2Terminated
- Sponsor
- Stanford University
- Start
- Jan 2008
- Primary completion
- Dec 2009
- Countries
- 1
01
Overview
A Phase 2 trial of vandetanib in breast cancer, sponsored by Stanford University. Started Jan 2008; status: terminated.
02
Drugs
vandetanib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00481845.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00481845.